Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1286 | Bestrophin 2 Blocking Peptide (AC1286) | 250 µg |
Bestrophin 2 Blocking Peptide for Immmunodepletion, Competition Assay
|
inquiry |
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg |
Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1288 | C9orf72 Blocking Peptide (AC1288) | 250 µg |
C9orf72 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1289 | Usherin Blocking Peptide (AC1289) | 250 µg |
Usherin Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg |
Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1291 | FGFR1 Blocking Peptide (AC1291) | 250 µg |
FGFR1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1292 | Nkx2.2 Blocking Peptide (AC1292) | 250 µg |
Nkx2.2 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1293 | TORC2 Blocking Peptide (AC1293) | 250 µg |
TORC2 Blocking Peptide for Immunocompeition, Immunodepletion
|
inquiry |
| ACPP-1294 | DCC Blocking Peptide (AC1294) | 250 µg |
DCC Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1295 | Human ASPH Protein (AC1295) | 5 µg |
Aspartate Beta-Hydroxylase Human Recombinant
|
inquiry |
| ACPP-1296 | Human FGF 19 Protein (AC1296) | 5 µg |
Fibroblast Growth Factor-19 Human Recombinant
|
inquiry |
| ACPP-1297 | p75 NGF Receptor Blocking Peptide (AC1297) | 250 µg |
p75 NGF Receptor Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg |
Syndecan-1 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1299 | Calretinin Blocking Peptide (AC1299) | 250 µg |
Calretinin Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1300 | GTP cyclohydrolase 1 Blocking Peptide (AC1300) | 250 µg |
GTP cyclohydrolase 1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.